Elisabeth C. Moyal
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma.
Journal: Neuro-oncology advances
Published: May 30, 2024
Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities.
Journal: Clinical and translational radiation oncology
Published: May 25, 2024
Challenges in glioblastoma research: focus on the tumor microenvironment.
Journal: Trends in cancer
Published: January 03, 2022
Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review.
Journal: Cancers
Published: October 11, 2021
Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy.
Journal: Cancers
Published: June 11, 2021
Interactions between glioma and pregnancy: insight from a 52-case multicenter series.
Journal: Journal of neurosurgery
Published: March 17, 2017
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Journal: Acta neuropathologica
Published: July 20, 2016
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.
Journal: Neuro-oncology
Published: December 20, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026